S

Soleno Therapeutics
D

SLNO

46.090
USD
-1.26
(-2.66%)
مغلق
حجم التداول
11,332
الربح لكل سهم
-2
العائد الربحي
-
P/E
-17
حجم السوق
1,987,282,441
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet forthe treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.